Neoprobe to Present at JMP Securities Healthcare Conference
22 September 2011 - 2:30PM
Business Wire
Neoprobe Corporation (NYSE Amex: NEOP), a diversified developer
of innovative oncology surgical and diagnostic products, today
announced that Brent Larson, Neoprobe’s Senior Vice President and
Chief Financial Officer, will deliver a presentation to
institutional investors at 1:00 PM ET, Wednesday, September 28,
2011 at the JMP Securities Healthcare Conference, taking place at
The St. Regis, New York.
Investors and the public are invited to listen to a live webcast
of Mr. Larson’s presentation at http://wsw.com/webcast/jmp14/neop/.
An archived edition of the presentation will be available for 30
days following the presentation.
About Neoprobe
Neoprobe Corporation (NYSE Amex: NEOP) is a biomedical company
focused on enhancing oncology patient care and improving patient
benefit through radiopharmaceutical product development. Neoprobe
is actively developing two radiopharmaceutical agent platforms –
Lymphoseek® and RIGScanTM CR – to help surgeons better identify and
treat certain types of cancer. Neoprobe’s subsidiary, Cira
Biosciences, Inc., is also exploring development of a
patient-specific cellular therapy technology platform called ACT.
Neoprobe’s strategy is to deliver superior growth and shareholder
return by bringing to market novel radiopharmaceutical agents and
advancing the Company’s pipeline program through continued
investment and selective acquisitions. For more information, please
visit www.neoprobe.com.
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Neoprobe Corp. Common Stock (AMEX:NEOP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Neoprobe Corp. Common Stock (Amerikanische Börse): 0 Nachrichtenartikel
Weitere Neoprobe Corporation News-Artikel